Controlling for severity of illness in assessment of the association between antimicrobial-resistant infection and mortality: Impact of calculation of acute physiology and chronic health evaluation (APACHE) II scores at different time points

被引:14
作者
Hamilton, Keith W.
Bilker, Warren B.
Lautenbach, Ebbing
机构
[1] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Ctr Res & Educ Therapeut, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA
关键词
D O I
10.1086/518751
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. In studies of the association between antibiotic-resistant infection and mortality, the importance of controlling for the underlying severity of illness is well recognized. However, it is unclear when the severity of illness should be assessed. Controlling for severity of illness on the day the culture specimen is obtained may underestimate the true association between resistance and mortality. Objective. To assess the impact of calculating the Acute Physiology and Chronic Health Evaluation (APACHE) II score at different time points on the association between antimicrobial resistance and mortality. Methods. We used an existing data set from a study that investigated the association between fluoroquinolone resistance and mortality. The APACHE II score was calculated at 3 time points: the day the culture specimen was obtained, 1 day before the culture specimen was obtained, and 2 days before the culture specimen was obtained. Separate multivariable models were constructed using the 3 different APACHE II scores. These models were compared qualitatively. Results. Of 91 total subjects, 51 were infected with a fluoroquinolone-resistant strain and 40 with a fluoroquinolone-susceptible strain. The median APACHE II score for all subjects was 13 (95% confidence interval [CI], 11-15) when calculated on the day the culture specimen was obtained, 12 (95% CI, 11-13) when calculated 1 day before, and 11 (95% CI, 10-13) when calculated 2 days before the culture specimen was obtained. Of 91 subjects, 12 (13.2%) died. The 3 multivariable models (each with the APACHE II score calculated on a different day) were not substantively different; the adjusted odds ratio for the association between fluoroquinolone-resistant infection and mortality varied only from 1.38 to 1.65 in the 3 models. Conclusions. APACHE II scores calculated at different time points relative to obtainment of the culture specimen did not differ substantively. Furthermore, when the adjusted association between fluoroquinolone resistance and mortality was assessed, there were no substantive differences across multivariable models that incorporated APACHE II scores calculated at different time points.
引用
收藏
页码:832 / 836
页数:5
相关论文
共 21 条
[1]  
CLSI Manual Clinical and Laboratory Standards Institute, 2006, M100S16 CLSI
[2]   The relationship between antimicrobial resistance and patient outcomes: Mortality, length of hospital stay, and health care costs [J].
Cosgrove, SE .
CLINICAL INFECTIOUS DISEASES, 2006, 42 :S82-S89
[3]   The impact of antimicrobial resistance on health and economic outcomes [J].
Cosgrove, SE ;
Carmeli, Y .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (11) :1433-1437
[4]   Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia:: A meta-analysis [J].
Cosgrove, SE ;
Sakoulas, G ;
Perencevich, EN ;
Schwaber, MJ ;
Karchmer, AW ;
Carmeli, Y .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (01) :53-59
[5]   Methodologic issues of case-control studies: A review of established and newly recognized limitations [J].
D'Agata, EMC .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2005, 26 (04) :338-341
[6]   Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: A meta-analysis [J].
DiazGranados, CA ;
Zimmer, SM ;
Klein, M ;
Jernigan, JA .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (03) :327-333
[7]   Clinical impact and relevance of antibiotic resistance [J].
French, GL .
ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (10) :1514-1527
[8]   CDC DEFINITIONS FOR NOSOCOMIAL INFECTIONS, 1988 [J].
GARNER, JS ;
JARVIS, WR ;
EMORI, TG ;
HORAN, TC ;
HUGHES, JM .
AMERICAN JOURNAL OF INFECTION CONTROL, 1988, 16 (03) :128-140
[9]   MODELING AND VARIABLE SELECTION IN EPIDEMIOLOGIC ANALYSIS [J].
GREENLAND, S .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1989, 79 (03) :340-349
[10]  
Hosmer D, 2000, Applied Logistic Regression, V2nd, DOI DOI 10.1002/0471722146.CH4